Home
Home
Podcasts
Podcasts
Library
Cancel
Sign in
Lilly weight loss drug succeeds in sleep apnea trial
Wall Street Breakfast
Apr 17 2024 • 5 mins
Zepbound sees
positive outcomes
in Phase 3 clinical trials for sleep disorder. (0:16) Walmart
teams up
with Jessica Simpson. (3:25) Cathie Wood's flagship ARRK ETF f
alls below
key technical level. (3:42)
Show Notes
Wedbush says these housing stocks can benefit from rising interest rates
Episode transcripts
seekingalpha.com/wsb
Sign up for our daily newsletter
here
and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at
seekingalpha.com/subscriptions
.
You Might Like
NPR News Now
NPR
The Daily
The New York Times
Up First
NPR
The Dan Bongino Show
Cumulus Podcast Network | Dan Bongino
WSJ What’s News
The Wall Street Journal
CNN 5 Things
CNN
Pod Save America
Crooked Media
The Rachel Maddow Show
Rachel Maddow, MSNBC
Serial
Serial Productions & The New York Times
The Megyn Kelly Show
SiriusXM
Morning Joe
Joe Scarborough and Mika Brzezinski, MSNBC
Mark Levin Podcast
Cumulus Podcast Network
The Glenn Beck Program
Blaze Podcast Network
The Ben Shapiro Show
The Daily Wire
WSJ Your Money Briefing
The Wall Street Journal
Morning Wire
The Daily Wire
The NPR Politics Podcast
NPR
The Fox News Rundown
FOX News Radio
Start Here
ABC News
The Matt Walsh Show
The Daily Wire